Reaktion #2179029

ord-8149863df1d04c5da18f978de6b9685c

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Sonstigeto produce
  2. 2
    Sonstige10.2 mg of 113 following reverse phase HPLC purification

Vorschrift

4-(2-chloro-6-((3-(tetrahydro-2H-pyran-4-yl)azetidin-1-yl)methyl)pyrido[3,2-d]pyrimidin-4-yl)morpholine from Example 111 (0.1 g) was reacted with 2-isopropyl-1H-benzo[d]imidazole via General Procedure C to produce 10.2 mg of 113 following reverse phase HPLC purification. MS (Q1) 528.3 (M)+

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US08440651B2uspto-grants-2013_05